基于Gossypol的纳米载体用于癌症治疗:进展和未来的前景
Sambhavi Swarn1, Ali M Alaseem2, Sachin Sharma3
1Shree Dhanvantary Pharmacy College, Olpad, Surat 394110, Gujarat, India.
Journal of biomaterials science. Polymer edition
|September 12, 2025
概括
戈西波尔是一种天然的抗癌化合物,面临着交付挑战. 纳米载体系统提高了它的有效性,并减少了对改善癌症治疗的毒性.
科学领域:
- 自然产品化学 自然产品化学
- 纳米医学是一种纳米医学.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 果西波尔是一种植物性多类化物,通过向关键细胞通路,表现出强大的抗癌特性.
- 戈西波尔的临床使用受到溶解性差,新陈代谢快速,全身毒性和低生物利用度的阻碍.
- 纳米载体药物递送系统为克服这些局限性提供了一个有希望的方法.
研究的目的:
- 审查gossypol的药理特征和抗癌机制.
- 探索各种纳米载体平台,以提高gossypol的治疗指数.
- 讨论在癌症治疗中使用gossypol装载纳米载体的挑战和未来方向.
主要方法:
- 关于gossypol的药理学和抗癌机制的综合文献综述.
- 分析各种纳米载体系统 (脂质体,纳米颗粒,树状体,小粒等) 的分析. 为了Gossypol的交付.
- 纳米载体开发的配方,毒性和监管方面的检查.
主要成果:
- 戈西波尔有效调节细胞亡,血管生成和细胞循环停止.
- 工程纳米载体显著提高了gossypol的稳定性,生物可用性和向传递.
- 各种纳米载体平台在体外和体外模型中显示出增强的抗癌疗效.
结论:
- 装有Gossypol的纳米载体显示出克服常规限制的巨大潜力,改善治疗指数.
- 新兴的趋势,如外体介导和仿生传递,为基于gossypol的纳米医学提供了新的途径.
- 纳米载体技术为gossypol作为有效的抗癌剂的临床转化提供了希望.
更多相关视频
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Drug Delivery: Overview
730
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
730
Cancer Vaccines
976
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
976
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


